Late hepatitis B reactivation following direct-acting antiviral-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.

Details

Serval ID
serval:BIB_DD329BAFA656
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Late hepatitis B reactivation following direct-acting antiviral-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.
Journal
Hepatology
Author(s)
Vionnet J., Pascual M., Testoni B., Combet C., Godat S., Vijgen S., Aubert V., Rubbia-Brandt L., Zoulim F., Moradpour D.
ISSN
1527-3350 (Electronic)
ISSN-L
0270-9139
Publication state
Published
Issued date
16/09/2017
Peer-reviewed
Oui
Volume
67
Number
2
Pages
791-793
Language
english
Notes
Publication types: Journal Article

Abstract
Direct-acting antivirals (DAAs) have changed the landscape of hepatitis C virus (HCV) treatment, but chronic hepatitis C (CHC) remains a leading indication for liver transplantation (LT). Hepatitis B virus (HBV) reactivation has been reported in HBV-HCV-coinfected patients treated with DAAs. We report on a case of late HBV reactivation after DAA-based treatment of recurrent hepatitis C in an antibody against hepatitis B core antigen (anti-HBc)-positive LT recipient. (Hepatology 2017).

Keywords
HBV-HCV coinfection, direct-acting antiviral, liver transplantation, replication space, viral interference
Pubmed
Web of science
Create date
05/10/2017 9:40
Last modification date
07/10/2019 15:48
Usage data